CTXR stock news
This page provides real-time market news, earnings updates, and company announcements related to Citius Pharmaceuticals, Inc. (CTXR).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-03-09 04:58 EST
Citius Oncology (CTOR) Expands LYMPHIR Distribution to Europe Through Exclusive Agreement With Uniphar
Finviz2026-02-24 14:39:07
Citius Oncology, Inc. announces preliminary topline data from its study in high-risk diffuse large B-cell lymphoma patients
老虎证券2026-03-04 14:32:59
Citius Oncology, Inc. announces preliminary topline data from its study in high-risk diffuse large B-cell lymphoma patients
老虎证券2026-03-04 14:37:45
Citius Oncology, Inc. announces preliminary topline data from its study in high-risk diffuse large B-cell lymphoma patients
老虎证券2026-03-04 14:40:07
CTXR stock chart
CTXR stock detailsCTXR stock price change
On the last trading day, CTXR stock closed at 0.84 USD, with a price change of -11.97% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more